Approval · Notice of Compliance 12924 · 2012
MILBEMITE: Notice of Compliance 12924
Issued January 16, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12924
- Date
- January 16, 2012
- Company
- Novartis Animal Health Canada Inc.Mississauga, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility and nds packaging
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MILBEMITE | 02246889 | Cancelled Post Market |
Medicinal ingredients
- MILBEMYCIN OXIME 0.1 PER